Catalyst Wire Dossier Catalyst Wire Dossier

SUPLEXA

· Alloplex Biotherapeutics Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SUPLEXA, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies [Phase 1]

See pricing